{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-092672","form_type":"8-K","ticker":"KTTA","cik":"0001841330","company_name":"Pasithea Therapeutics Corp.","filed_at":"2026-08-21T21:05:14+00:00","discovered_at":"2026-08-21T21:06:34.457546+00:00","generated_at":"2026-08-21T21:06:39.523888+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Pasithea gets Nasdaq 180-day extension to Feb 16, 2027 for bid-price rule","bullets":["Nasdaq notified Feb 20, 2026 of non-compliance with $1.00 minimum bid price rule 5550(a)(2).","On Aug 20, 2026, Nasdaq granted 180-day extension to Feb 16, 2027 to regain compliance.","Company may implement reverse stock split to cure; delisting and appeal rights if not cured.","No assurance compliance will be achieved within the extension period."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-092672","json":"https://secwatch.observer/filing/0001213900-26-092672.json","markdown":"https://secwatch.observer/filing/0001213900-26-092672.md","text":"https://secwatch.observer/filing/0001213900-26-092672.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841330/000121390026092672/0001213900-26-092672-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841330/000121390026092672/ea0302993-8k_pasithea.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-21T21:06:39.523888+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}